Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Interest & Investment Income (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Interest & Investment Income data on record, last reported at $687000.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income rose 59.77% year-over-year to $687000.0; the TTM value through Sep 2025 reached $779000.0, down 72.5%, while the annual FY2024 figure was $1.8 million, 10.92% down from the prior year.
  • Interest & Investment Income reached $687000.0 in Q3 2025 per GOSS's latest filing, up from $542000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.7 million in Q2 2024 and bottomed at -$744000.0 in Q4 2024.
  • Average Interest & Investment Income over 4 years is $458800.0, with a median of $430000.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 162.05% in 2023, then tumbled 340.0% in 2024.
  • A 4-year view of Interest & Investment Income shows it stood at $594000.0 in 2022, then plummeted by 47.81% to $310000.0 in 2023, then crashed by 340.0% to -$744000.0 in 2024, then surged by 192.34% to $687000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $687000.0 in Q3 2025, $542000.0 in Q2 2025, and $294000.0 in Q1 2025.